Seizure Induced by Extended-Release Bupropion Used for Smoking Cessation at Early Term and Therapeutic Dose [PDF]
Archives of Epilepsy, 2018 Bupropion inhibits reuptakes of dopamine and noradrenaline. Since it is also a nicotine receptor antagonist, it acts as a drug used for smoking cessation. Bupropion is commonly preferred because of no side effects on weight, sexual function, and the lack
Zeynep ÖZÖZEN AYAS +1 more
doaj +2 more sources
Hallucinations during bipolar depressive episode treated with bupropion after alcohol withdrawal surgery: a case report [PDF]
Frontiers in PsychiatryAlcohol Use Disorder (AUD) is a prevalent condition often co-occurring with affective disorders. Bupropion, a medication used to treat affective disorders, acts by inhibiting dopamine (DA) and norepinephrine (NE) reuptake, potentially helping to ...
Xiangqi Kong +5 more
doaj +2 more sources
A novel dosage form for buccal administration of bupropion [PDF]
Brazilian Journal of Pharmaceutical Sciences, 2015 Bupropion is an antidepressant used in the treatment of smoking. The purpose of this study was to prepare controlled-release hydrogel films for buccal administration of bupropion and investigate its physicochemical and cytotoxic properties.
Nilsa Maria Galvão Almeida +5 more
doaj +5 more sources
Combined lipid emulsion and plasma exchange in massive pediatric bupropion overdose: Case Report [PDF]
Frontiers in ToxicologyIntroductionMassive bupropion overdose in pediatric patients can result in refractory cardiogenic shock, seizures, and cardiac arrest requiring aggressive intervention.
Brett Russell +6 more
doaj +2 more sources
Charcoal hemoperfusion in bupropion overdose [PDF]
Journal of the Formosan Medical Association, 2014 Bupropion is a relatively new and popular medication for depression, with seizures as its major side effect. In the literature, there are insufficient data about hemodialysis following bupropion overdose.
Hızır Ufuk Akdemir +5 more
doaj +2 more sources
Is There a Potential of Misuse for Venlafaxine and Bupropion? [PDF]
Frontiers in Pharmacology, 2018 Objective: Traditionally, studies on the non-medical use of pharmaceutical products have focused on controlled substances; e.g., opiates/opioids; and benzodiazepines.
Fabrizio Schifano, Stefania Chiappini
doaj +3 more sources
Drugs of Today, 2006 Bupropion was initially developed and licensed for the treatment of major depressive disorder in the United States in 1989. It was licensed as a pharmacotherapy for smoking cessation in the United States in 1997 and in the United Kingdom in 2000, and for the prevention of seasonal major depressive episodes in patients with seasonal affective disorder ...
europepmc +3 more sources
Bupropion Reduces Some of the Symptoms of Marihuana Withdrawal in Chronic Marihuana Users: A Pilot Study [PDF]
Substance Abuse: Research and Treatment, 2012 Bupropion's (Zyban ® SR) effectiveness to treat symptoms experienced in marihuana withdrawal was tested in a double-blind, placebo-controlled study with chronic, heavy marihuana users.
David M. Penetar +4 more
doaj +2 more sources
A Meta-Analysis of the Efficacy of Bupropion Sustained-Release for Smoking Cessation in Heavy Smokers [PDF]
Impulse: The Premier Undergraduate Neuroscience Journal, 2017 Cigarette smoking damages just about every organ in the body and reduces overall health. Even with the prevalence of accessible nicotine replacement therapies and behavioral counseling, there remains a need for alternative therapies to improve the odds ...
Adrian Paszek
doaj +2 more sources
Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
Toxicology Communications, 2021 Introduction Bupropion overdose can produce seizures, arrhythmias, and shock. The toxicokinetics of massive bupropion ingestions are not well characterized.Case report A 22-year-old female ingested an estimated 40.5 g (644 mg/kg) of extended release ...
Michael E. O’Brien +5 more
doaj +1 more source